Roger D. Tung
2015
In 2015, Roger D. Tung earned a total compensation of $711K as President and Chief Executive Officer at Concert Pharmaceuticals, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,211 |
|---|---|
| Salary | $435,537 |
| Other | $13,256 |
| Total | $711,004 |
Tung received $435.5K in salary, accounting for 61% of the total pay in 2015.
Tung also received $262.2K in non-equity incentive plan and $13.3K in other compensation.
Rankings
In 2015, Roger D. Tung's compensation ranked 9,464th out of 13,638 executives tracked by ExecPay. In other words, Tung earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,464 out of 13,638 | 31st |
Division Manufacturing | 3,610 out of 5,190 | 30th |
Major group Chemicals And Allied Products | 1,317 out of 1,854 | 29th |
Industry group Drugs | 1,075 out of 1,528 | 30th |
Industry Pharmaceutical Preparations | 841 out of 1,182 | 29th |
Source: SEC filing on April 26, 2017.
Tung's colleagues
We found two more compensation records of executives who worked with Roger D. Tung at Concert Pharmaceuticals in 2015.
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019